Evolus (NASDAQ: EOLS) reported Q2 EPS of ($0.32), $0.06 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $49.3 million versus the consensus estimate of $46.24 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.